Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion type Assertion NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_head.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion evidence source_evidence_literature NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion SIO_000772 21270202 NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion wasDerivedFrom befree-20150227 NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion wasGeneratedBy ECO_0000203 NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.